Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Geisslinger

Showing results (201-210 of 441) with videos related to

Pageof 45
Sort By:
Molecular Immunology|June 11, 2017
THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitroHiromi Shiratori, Carmen Feinweber, Sonja Luckhardt, et al.
The Clinical Journal of Pain|October 24, 2009
Cross-sectional assessment of the consequences of a GTP cyclohydrolase 1 haplotype for specialized tertiary outpatient pain careAlexandra Doehring, Rainer Freynhagen, Norbert Griessinger, et al.
Cytokine|June 26, 2017
CXCL16/CXCR6-mediated adhesion of human peripheral blood mononuclear cells to inflamed endotheliumBona Linke, Sascha Meyer Dos Santos, Bettina Picard-Willems, et al.
Journal of Neurochemistry|February 6, 2004
Protein associated with Myc (PAM) is involved in spinal nociceptive processingCorina Ehnert, Irmgard Tegeder, Sandra Pierre, et al.
Antiviral Therapy|December 15, 2010
Screening for IL28B gene variants identifies predictors of hepatitis C therapy successAlexandra Doehring, Wolf Peter Hofmann, Christina Schlecker, et al.
Molecular Immunology|May 4, 2007
FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functionsCarolin Daniel, Nico A Sartory, Nadine Zahn, et al.
Biochemical Pharmacology|May 30, 2008
Dimethylcelecoxib inhibits prostaglandin E2 productionIvonne Wobst, Susanne Schiffmann, Kerstin Birod, et al.
Pharmaceutical Research|January 29, 2014
Similar maximum systemic but not local cyclooxygenase-2 inhibition by 50 mg lumiracoxib and 90 mg etoricoxib: a randomized controlled trial in healthy subjectsLisa Felden, Carmen Walter, Carlo Angioni, et al.
Biochemical Pharmacology|June 13, 2008
The anti-proliferative potency of celecoxib is not a class effect of coxibsSusanne Schiffmann, Thorsten Jürgen Maier, Ivonne Wobst, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 6, 2023
Distinct molecular mechanisms contribute to the reduction of melanoma growth and tumor pain after systemic and local depletion of alpha-Synuclein in miceEllen Niederberger, Moritz Möller, Eleonora Mungo, et al.
Pageof 45

Showing results (201-210 of 441) with videos related to

Sort By:
Pageof 45
Molecular Immunology|June 11, 2017
THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitroHiromi Shiratori, Carmen Feinweber, Sonja Luckhardt, et al.
The Clinical Journal of Pain|October 24, 2009
Cross-sectional assessment of the consequences of a GTP cyclohydrolase 1 haplotype for specialized tertiary outpatient pain careAlexandra Doehring, Rainer Freynhagen, Norbert Griessinger, et al.
Cytokine|June 26, 2017
CXCL16/CXCR6-mediated adhesion of human peripheral blood mononuclear cells to inflamed endotheliumBona Linke, Sascha Meyer Dos Santos, Bettina Picard-Willems, et al.
Journal of Neurochemistry|February 6, 2004
Protein associated with Myc (PAM) is involved in spinal nociceptive processingCorina Ehnert, Irmgard Tegeder, Sandra Pierre, et al.
Antiviral Therapy|December 15, 2010
Screening for IL28B gene variants identifies predictors of hepatitis C therapy successAlexandra Doehring, Wolf Peter Hofmann, Christina Schlecker, et al.
Molecular Immunology|May 4, 2007
FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functionsCarolin Daniel, Nico A Sartory, Nadine Zahn, et al.
Biochemical Pharmacology|May 30, 2008
Dimethylcelecoxib inhibits prostaglandin E2 productionIvonne Wobst, Susanne Schiffmann, Kerstin Birod, et al.
Pharmaceutical Research|January 29, 2014
Similar maximum systemic but not local cyclooxygenase-2 inhibition by 50 mg lumiracoxib and 90 mg etoricoxib: a randomized controlled trial in healthy subjectsLisa Felden, Carmen Walter, Carlo Angioni, et al.
Biochemical Pharmacology|June 13, 2008
The anti-proliferative potency of celecoxib is not a class effect of coxibsSusanne Schiffmann, Thorsten Jürgen Maier, Ivonne Wobst, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 6, 2023
Distinct molecular mechanisms contribute to the reduction of melanoma growth and tumor pain after systemic and local depletion of alpha-Synuclein in miceEllen Niederberger, Moritz Möller, Eleonora Mungo, et al.
Pageof 45